Hostname: page-component-586b7cd67f-r5fsc Total loading time: 0 Render date: 2024-11-27T03:25:04.818Z Has data issue: false hasContentIssue false

Is It Valid to Compare Surgical Site Infections Rates Between Countries? Insights From a Study of English and Norwegian Surveillance Systems

Published online by Cambridge University Press:  08 November 2016

Hinta Meijerink
Affiliation:
Department of Antibiotic Resistance and Infection Prevention, Norwegian Institute for Public Health, Oslo, Norway European Programme for Intervention Epidemiology Training (EPIET), European Centre for Disease Prevention and Control, (ECDC), Stockholm, Sweden
Theresa Lamagni
Affiliation:
National Infection Service, Public Health England, London, United Kingdom
Hanne Merete Eriksen
Affiliation:
Department of Antibiotic Resistance and Infection Prevention, Norwegian Institute for Public Health, Oslo, Norway
Suzanne Elgohari
Affiliation:
National Infection Service, Public Health England, London, United Kingdom
Pauline Harrington
Affiliation:
National Infection Service, Public Health England, London, United Kingdom
Oliver Kacelnik*
Affiliation:
Department of Antibiotic Resistance and Infection Prevention, Norwegian Institute for Public Health, Oslo, Norway
*
Address correspondence to Oliver Kacelnik, Norwegian Institute of Public Health, Domain of Infection Control and Environmental Health. P.O. Box 4404, Nydalen, NO–0403 Oslo, Norway ([email protected]).

Abstract

OBJECTIVE

To assess whether differences in surveillance methods or underlying populations significantly influence internationally reported national SSI rates by comparing surveillance data from 2 countries.

DESIGN

Retrospective cohort.

SETTING

England and Norway.

METHODS

We assessed the population under surveillance and surveillance methodology to compare SSI rates in 2 countries (September 2012–January 2015) for 4 surgical categories: coronary artery bypass graft (CABG), colon surgery, cholecystectomy, and hip prosthesis (HPRO). We compared the inpatient SSI incidence using logistic regression, adjusting for the following known risk factors: sex, age, ASA score, wound class, postoperative hospital days, and operation duration. Subsequently, we restricted further analyses to the procedures reported by both countries.

RESULTS

There were important differences in case definitions for superficial infection, so we restricted our analyses to deep incisional and organ-space SSIs. For CABG, the crude odds ratio (OR) for England compared to Norway was 2.4 (95% CI, 1.4–4.4), whereas adjusted OR (aOR) lost significance (aOR, 1.1; 95% CI, 0.57–2.0). For colon surgery the decreased odds (OR, 0.68; 95% CI, 0.56–0.81) remained significant after adjustment (aOR, 0.42; 95% CI, 0.34–0.51). We found no associations for cholecystectomy. For HPRO, the crude OR suggested no significant difference (OR, 1.2; 95% CI, 0.72–2.1), whereas the aOR was significantly lower in England (aOR, 0.45; 95% CI, 0.25–0.81). Including only the subset of procedures reported by both countries yielded comparable results.

CONCLUSION

Differences in case definitions and population under surveillance in the English and Norwegian SSI surveillance systems affected SSI estimates, making the comparison of crude rates unreliable. Standardized definitions and adjustment for established risk factors are essential for European comparisons to guide related public health actions.

Infect Control Hosp Epidemiol 2017;38:162–171

Type
Original Articles
Copyright
© 2016 by The Society for Healthcare Epidemiology of America. All rights reserved 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1. Plowman, R, Graves, N, Griffin, MA, et al. The rate and cost of hospital-acquired infections occurring in patients admitted to selected specialties of a district general hospital in England and the national burden imposed. J Hosp Infect 2001;47:198209.Google Scholar
2. Cahill, JL, Shadbolt, B, Scarvell, JM, Smith, PN. Quality of life after infection in total joint replacement. J Orthop Surg (Hong Kong) 2008;16:5865.Google Scholar
3. Coello, R, Charlett, A, Wilson, J, Ward, V, Pearson, A, Borriello, P. Adverse impact of surgical site infections in English hospitals. J Hosp Infect 2005;60:93103.Google Scholar
4. European Centre for Disease Prevention and Control. Surveillance of Surgical Site Infections in European Hospitals—HAISSI protocol Version 1.02. Stockholm: ECDC; 2012.Google Scholar
5. Wilson, AP, Hodgson, B, Liu, M, et al. Reduction in wound infection rates by wound surveillance with postdischarge follow-up and feedback. Br J Surg 2006;93:630638.Google Scholar
6. Sparling, KW, Ryckman, FC, Schoettker, PJ, et al. Financial impact of failing to prevent surgical site infections. Qual Manag Health Care 2007;16:219225.Google Scholar
7. Gastmeier, P, Sohr, D, Schwab, F, et al. Ten years of KISS: the most important requirements for success. J Hosp Infect 2008;70(Suppl 1):1116.Google Scholar
8. Infection prevention and control. World Health Organization website. http://www.who.int/gpsc/ipc/en/. Published 2016. Accessed 25 April, 2016.Google Scholar
9. Mannien, J, van den Hof, S, Brandt, C, Behnke, M, Wille, JC, Gastmeier, P. Comparison of the National Surgical Site Infection surveillance data between The Netherlands and Germany: PREZIES versus KISS. J Hosp Infect 2007;66:224231.Google Scholar
10. Harrington, P, Wloch, C, Elgohari, S, Lamagni, T. Protocol for Surveillance of Surgical Site Infection. Public Health England; 2013.Google Scholar
11. Norwegian Surveillance System for Healthcare-Associated Infections (NOIS). Norwegian Institute of Public Health Department of Infectious Disease Epidemiology website. http://www.fhi.no/dokumenter/4a599a88c2.pdf. Published 2009. Accessed February 18, 2016.Google Scholar
12. Lower, HL, Eriksen, HM, Aavitsland, P, Skjeldestad, FE. The quality of denominator data in surgical site infection surveillance versus administrative data in Norway 2005–2010. BMC Infect Dis 2015;15:549.Google Scholar
13. Haustein, T, Gastmeier, P, Holmes, A, et al. Use of benchmarking and public reporting for infection control in four high-income countries. Lancet Infect Dis 2011;11:471481.Google Scholar
14. Martin, M, Zingg, W, Hansen, S, et al. Public reporting of healthcare-associated infection data in Europe. What are the views of infection prevention opinion leaders? J Hosp Infect 2013;83:9498.Google Scholar
15. Wilson, AP, Gibbons, C, Reeves, BC, et al. Surgical wound infection as a performance indicator: agreement of common definitions of wound infection in 4773 patients. BMJ 2004;329:720.Google Scholar